Search Results - "Gold, K.A"

Pretreatment Complete Blood Count Improves Prognostic Model Survival Prediction in Oropharyngeal Cancer Patients Treated With Radiation Therapy by Mohamed, A.S.R, Shoultz-Henley, S, Garden, A.S, Sheu, T, Kroll, M, Rosenthal, D.I, Gunn, G.B, Phan, J, Lai, S, Kies, M.S, Gold, K.A, Sturgis, E.M, Fuller, C.D

Get full text

Prognostic Value of Pretherapy Platelet Elevation in Oropharyngeal Cancer Patients Treated With Chemoradiation by Shoultz-Henley, S, Garden, A.S, Mohamed, A.S.R, Sheu, T, Kroll, M, Rosenthal, D.I, Gunn, G.B, Phan, J, Lai, S, Kies, M.S, Gold, K.A, Sturgis, E.M, Fuller, C.D

Get full text

Identification and Management of Laryngeal Carcinoma Patients With Risk Factors for Gastrostomy Tube Placement by Lai, S, Huang, A.T, Tang, C, Hutcheson, K.A, Bender, M, Beadle, B.M, Gold, K.A, Lewin, J.S

Get full text

Postoperative IMRT for Patients With Oral Cavity Carcinoma by Quinlan-Davidson, S.R, Morrison, W.H, Myers, J.N, Gunn, G.B, Johnson, F.M, Beadle, B.M, Gillenwater, A.M, Phan, J, Frank, S.J, William, W.N, Fuller, C.D, Gold, K.A, Rosenthal, D.I, Garden, A.S

Get full text

81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases by Gettinger, S.N, Bazhenova, L, Salgia, R, Langer, C.J, Gold, K.A, Rosell, R, Shaw, A.T, Weiss, G.J, Narasimhan, N.I, Dorer, D.J, Rivera, V.M, Clackson, T, Haluska, F.G, Camidge, D.R

Get full text

Radiotherapy with Concurrent and Adjuvant Pembrolizumab in Patients with P16-Positive Locoregionally Advanced Head and Neck Cancer: KEYCHAIN Trial Lead-In Results by Sacco, A.G., Sharabi, A., Jing, Z., Pittman, E., Gold, K.A., Sumner, W., Califano, J.A., Brumund, K., Orosco, R.K., Rash, D.L., Coffey, C., Cohen, E., Mell, L.K.

Get full text

Translational insights and overall survival in the U31402-A-U102 study of patritumab deruxtecan (HER3-DXd) in EGFR-mutated NSCLC by Yu, H A, Baik, C, Kim, D-W, Johnson, M L, Hayashi, H, Nishio, M, Yang, J C-H, Su, W-C, Gold, K A, Koczywas, M, Smit, E F, Steuer, C E, Felip, E, Murakami, H, Kim, S-W, Su, X, Sato, S, Fan, P-D, Fujimura, M, Tanaka, Y, Patel, P, Sternberg, D W, Sellami, D, Jänne, P A

“…Human epidermal growth factor receptor 3 (HER3) is broadly expressed in non-small-cell lung cancer (NSCLC) and is the target of patritumab deruxtecan…”
Get more information

An open-label, non-randomized, multi-arm, phase II trial evaluating pembrolizumab combined with cetuximab in patients (pts) with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): updated results of cohort 1 analysis by Sacco, A.G., Chen, R., Ghosh, D., Worden, F., Wong, D.J., Adkins, D., Swiecicki, P.L., Chai-Ho, W., Pittman, E., Messer, K., Gold, K.A., Daniels, G., Sutton, B., Natsuhara, A., Cohen, E.

Get full text

Brigatinib (BRG) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC): Long-term efficacy and safety results from a phase 1/2 trial by Bazhenova, L.A., Gettinger, S.N., Langer, C.J., Salgia, R., Gold, K.A., Rosell, R., Shaw, A.T., Weiss, G.J., Haney, J., Rivera, V.M., Kerstein, D., Camidge, R.

Get full text

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma by Haddad, R.I., Massarelli, E., Lee, J.J., Lin, H.Y., Hutcheson, K., Lewis, J., Garden, A.S., Blumenschein, G.R., William, W.N., Pharaon, R.R., Tishler, R.B., Glisson, B.S., Pickering, C., Gold, K.A., Johnson, F.M., Rabinowits, G., Ginsberg, L.E., Williams, M.D., Myers, J., Kies, M.S., Papadimitrakopoulou, V.

“…The survival advantage of induction chemotherapy (IC) followed by locoregional treatment is controversial in locally advanced head and neck squamous cell…”
Get full text

Development of Care Pathway Models to Standardize and Optimally Integrate Multidisciplinary Services in the Management of Head and Neck Cancer by Sacco, A.G., Coffey, C., Sanghvi, P., Rubio, G.P., Califano, J.A., Athas, J., Tamayo, G.J., Linnemeyer, K., Orosco, R.K., Brumund, K., Cohen, E., Gold, K.A., Mell, L.K., Sharabi, A., Daniels, G., Abbott, Y., Collins, R., Clynch, K., Noboa, M., Blumenfeld, L.

Get full text

Gefitinib for advanced non-small-cell lung cancer and quality of life: expanding and improving treatment options by William, W.N., Gold, K.A., Kim, E.S.

Get full text